Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN86138886) titled 'Personalized prostate cancer prevention and management' on Oct. 3.
Study Type: Observational
Study Design:
Prospective observational trial with ancillary real-world longitudinal study (Prevention)
Primary Sponsor: Fondazione Edo ed Elvo Tempia
Condition:
Prostate cancer
Cancer
Intervention:
Longitudinal blood sampling is carried out with isolation and storage of plasma, serum and PBMCs
PSA dosage is performed from serum
analysis of circulating microRNAs, sphingolipids and proteins is carried out from plasma
totRNA-sequencing is done starting from fixed tissue
image analysis is performed on digital pathology...